Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
SightLine Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
SightLine Partners

SightLine Partners

Operating

SightLine Partners LLC: A US-based venture fund manager investing in late-stage medical technology firms.

Location
Bloomington, MN, US
Founded
2004
Firm
Compare
Portfolio
Employees
Website

SightLine Partners LLC is a US-based venture fund manager specializing in late-stage investments in medical technology, digital health, life sciences, and healthcare service companies. The firm primarily focuses on secondary buyouts and joint venture transactions, targeting high-quality portfolios within these sectors. SightLine Partners typically engages in Series B through Series F funding rounds, reflecting its emphasis on later-stage investments.

Notable portfolio companies include CVRx, Earlens, EndoGastric Solutions, Magnolia Medical Technologies, Vapotherm, and Verax Biomedical. As the successor to Piper Jaffray Ventures, SightLine Partners leverages its extensive experience in healthcare venture capital to provide strategic guidance and support to its portfolio companies. The firm's key partners bring a wealth of expertise from their previous affiliations with Piper Jaffray Ventures, enhancing SightLine's ability to drive growth and innovation within the healthcare sector.

SightLine Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments16
Current Portfolio Count9
Total Portfolio Exits0

Top Investment Stages

Series C5 (38.5%)
Series D4 (30.8%)
Series Unknown2 (15.4%)
Series A1 (7.7%)
Series B1 (7.7%)

Stage Mix

Series C 38%Series D 31%Series Unknown 15%Series A 8%Series B 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Magnolia Medical Technologies logo

Magnolia Medical Technologies

Vapotherm logo

Vapotherm

EndoGastric Solutions logo

EndoGastric Solutions

Earlens logo

Earlens

Monteris Medical logo

Monteris Medical

Conventus Orthopaedics logo

Conventus Orthopaedics

Cvrx logo

Cvrx

Anulex Technologies logo

Anulex Technologies

Verax Biomedical logo

Verax Biomedical

SightLine Partners - Similar Investment Firms

VisionTech Partners logo

VisionTech Partners

Visionary Venture Fund logo

Visionary Venture Fund

visionaryvc.com

ExSight Ventures logo

ExSight Ventures

Skyline Ventures logo

Skyline Ventures

Kline Hill Partners logo

Kline Hill Partners

klinehill.com

Endeavour Vision logo

Endeavour Vision

Waterline Ventures logo

Waterline Ventures

Oceanic Partners logo

Oceanic Partners

oceanic.us

Lineage Capital logo

Lineage Capital

lineagecap.com

Vision Ridge Partners logo

Vision Ridge Partners

vision-ridge.com

Flare Capital Partners logo

Flare Capital Partners

flarecapital.com

Woodline Partners logo

Woodline Partners

Spring Lake Equity Partners logo

Spring Lake Equity Partners

springlep.com

Searchlight Capital Partners logo

Searchlight Capital Partners

searchlightcap.com

Insight Venture Partners logo

Insight Venture Partners

SightLine Partners - Classification

Also Known As
  • Sightline Partners LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
ISIC
  • 6619Other activities auxiliary to financial service activities
Show 9 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6200Security And Commodity Brokers, Dealers, Exchanges, And Services
  • 6280Services Allied With The Exchange Of Securities Or Commodities
  • 6720Investment Offices
  • 6282Investment Advice
  • 6722Management Investment Offices, Open-end